Paul Tudor Jones Veru Inc. Transaction History
Tudor Investment Corp Et Al
- $25.1 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding VERU
# of Institutions
136Shares Held
56.7MCall Options Held
817KPut Options Held
595K-
Black Rock Inc. New York, NY7.65MShares$4.36 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY6.48MShares$3.7 Million0.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.22MShares$3.55 Million0.0% of portfolio
-
Bio Impact Capital LLC Cambridge, MA4.29MShares$2.44 Million0.42% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.76MShares$2.15 Million0.0% of portfolio
About VERU INC.
- Ticker VERU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 80,146,704
- Market Cap $45.7M
- Description
- Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....